Workflow
底层创新
icon
Search documents
K2开源大模型,会是Kimi的DeepSeek时刻吗?
Hu Xiu· 2025-07-14 03:20
Core Insights - The article discusses the emergence of MoonShot's latest open-source model K2, which has a parameter scale of 1 trillion, making it the largest open-source model currently available [2] - K2's performance in various benchmarks positions it as a strong competitor against established models like Claude 4 Opus and GPT-4.1, highlighting China's growing influence in the global AI landscape [2][4] - The competitive landscape in the AI sector is intensifying, with Chinese companies like MoonShot and MiniMax leading the charge in open-source innovation, challenging Western counterparts [4][6] Company Developments - MoonShot's K2 model has quickly gained popularity, becoming the top trending open-source model on HuggingFace shortly after its release [4] - The model's architecture incorporates fewer attention heads and more experts, enhancing efficiency in processing long contexts, which is a significant improvement over previous models [8][10] - MoonShot has disclosed a total funding amount of approximately $1.5 billion, which is significantly lower than that of its Western competitors, indicating a more efficient operational model [6] Market Impact - K2's compatibility with OpenAI and Anthropic's API formats positions it favorably in the AI application development market, potentially allowing it to capture a significant share of the market [7] - The article notes that the competitive dynamics between MoonShot and DeepSeek have intensified, with both companies releasing multiple models aimed at various AI applications [5][12] - The focus on multi-agent collaboration and the integration of various models into K2 may enhance its commercial viability and market appeal [12]
中科创星李浩:中国硬科技投资远远不够,持续关注底层创新丨最前线
3 6 Ke· 2025-06-19 11:16
Core Viewpoint - China's hard technology investment is not overheated but is significantly insufficient, requiring collective efforts from society to enhance the financial system's confidence and understanding of technology [1] Group 1: Investment Landscape - Zhongke Chuangxing, founded in 2013, is a pioneer in hard technology investment, focusing on the transformation of excellent scientific research achievements from research institutions and universities [1] - As of June this year, the fund's managed scale exceeds 12 billion yuan, having invested in and incubated over 530 hard technology companies [1] - Zhongke Chuangxing maintains a rapid investment pace despite the contraction of dollar funds and difficulties in GP fundraising [1] Group 2: Investment Strategy - Zhongke Chuangxing is one of the fastest institutions in the market, with last year's project count equivalent to the total of 30 GPs [2] - The firm employs a unique risk-hedging logic, emphasizing a large project pool to diversify risks, where 50 out of 100 projects may fail, but top projects can cover losses [2] - The company is particularly focused on the AI sector, which, despite being hot, is still in its early development stage, and values breakthroughs in underlying technologies such as quantum computing and controlled nuclear fusion [2] Group 3: Long-term Vision - Hard technology investments require "patient capital," with many projects co-invested with local future industry funds due to long investment cycles that can last up to 20 years [2] - Zhongke Chuangxing aims to balance long-term value with short-term exits by constructing a "research-incubation-industry" flywheel, binding early with research projects and later introducing industrial capital [2] - The company emphasizes the need for more "last-mile" participants to improve the low conversion rate of China's scientific and technological achievements [3]
乐纯生物成功自研高通量过滤膜,以底层创新筑牢本土生物制药供应链安全防线
Huan Qiu Wang· 2025-05-06 09:37
【环球网科技报道 记者 张阳】近日,乐纯生物宣布其自主研发的Extreme™ PVDF除菌过滤膜取得重大突破,凭借高纯净度、高通量及低蛋白吸附三大核 心技术指标,实现了关键性能参数的国际领先水平,标志着中国本土生物工艺公司在保障供应链安全方面迈出了坚实的一步。 下游需求侧,供应链稳定促成国产自研机遇 面对全球供应链波动系数不断加大的挑战,乐纯生物深知源头研发能力的重要性。从2021年推出生物工艺薄膜Lekrius®膜到今年新推出的Extreme™ PVDF 滤膜,乐纯生物长期聚焦底层突破,在"双膜"(即film和membrane)材料科学源头构建技术护城河。 "夯实底层研发,才能支撑起应用产品研发的活跃度,形成门类齐全的自研产品矩阵,从而支撑起整个供应链的安全可控。"秦孙星强调。乐纯生物针对一 次性系统、细胞培养、过滤纯化三大类耗材,均采取了"攻坚底层研发、深耕应用研发、优化整体工艺"的策略,成功实现了旗下一次性配储液袋、生物反 应袋/生物反应器、细胞培养袋等产品的全国产化生产。 在过滤业务方面,随着PVDF滤膜自研并稳定量产,乐纯生物迅速推出了相应的除菌级、除病毒级过滤器产品,支持了不同领域的产品布局。公司 ...